Aduro Clean Technologies prices US$22.8M public offering and private placement
Aduro Clean Technologies Inc announced the pricing of a public offering and concurrent private placement to raise up to US$22,805,214. The public offering comprises 1,028,645 shares at US$15.20 each, while the LIFE Offering includes up to 471,698 shares at the same price. Canaccord Genuity acts as sole bookrunner, with the public offering expected to close on June 11, 2026.

*this image is generated using AI for illustrative purposes only.
Aduro Clean Technologies Inc announced the pricing of a public offering and concurrent private placement aiming to raise aggregate gross proceeds of up to US$22,805,214. The capital will be used to fund the design, engineering, and construction of a first-of-a-kind demonstration-scale industrial plant, along with ongoing research and development costs and general corporate purposes.
The underwritten U.S. and Canadian public offering consists of 1,028,645 common shares at a price of US$15.20 per share, generating gross proceeds of US$15,635,404 before deducting underwriting discounts and expenses. Concurrently, the company launched a non-brokered private placement, termed the LIFE Offering, of up to 471,698 common shares at the same offering price, targeting gross proceeds of up to US$7,169,810.
Canaccord Genuity is acting as the sole bookrunner for the public offering. The company entered into an underwriting agreement with Canaccord Genuity, representing the several underwriters involved in the transaction. The public offering is expected to close on or about June 11, 2026, subject to customary closing conditions, including the listing of the shares on the Toronto Stock Exchange and the Nasdaq Capital Market.
The public offering is being made pursuant to an effective shelf registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission. The related base shelf prospectus and prospectus supplement have been filed with securities regulatory authorities in British Columbia and Ontario. The LIFE Offering is being made to purchasers in all Canadian provinces except Québec, relying on the listed issuer financing exemption.
Offering Details
| Component | Type | Shares | Price Per Share | Gross Proceeds |
|---|---|---|---|---|
| Public Offering | Underwritten | 1,028,645 | US$15.20 | US$15,635,404 |
| LIFE Offering | Private Placement | Up to 471,698 | US$15.20 | Up to US$7,169,810 |
| Total | Up to 1,500,343 | Up to US$22,805,214 |
The closing of the public offering is not conditional on the closing of the LIFE Offering, and vice versa. The LIFE Offering may close in one or more tranches on or before a date not later than 45 days from the announcement date. Certain company insiders may participate in the LIFE Offering, which constitutes a related party transaction under Multilateral Instrument 61-101, though the company expects to rely on exemptions from formal valuation and minority shareholder approval requirements.
What is the expected timeline for the design, engineering, and construction of the demonstration-scale industrial plant?
How will the successful operation of the demonstration plant influence potential partnerships or commercial agreements?
What are the key milestones the company aims to achieve with the ongoing R&D funded by this capital raise?

























